Anesthetic management problems posed by therapeutic advances. II. Digitalis and glucagon.
D000368:Aged; D000758:Anesthesia / Q000009:adverse effects*; D000777:Anesthetics / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control; D002118:Calcium / Q000097:blood; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D004361:Drug Tolerance; D004562:Electrocardiography; D005260:Female; D005934:Glucagon / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008274:Magnesium / Q000097:blood; D010276:Parasympatholytics / Q000009:adverse effects; D011188:Potassium / Q000097:blood; D011229:Preanesthetic Medication; D013390:Succinylcholine / Q000009:adverse effects
D000777:Anesthetics; D002800:Cholinesterase Inhibitors; D004071:Digitalis Glycosides; D010276:Parasympatholytics; D005934:Glucagon; D008274:Magnesium; D013390:Succinylcholine; D011188:Potassium; D002118:Calcium